In an effort to keep our members current with the evolving Ebola outbreak in West Africa and prepared for any potential US response, IDSA has compiled numerous resources on the homepage of our website including:|
IDWeek, Oct. 8-12 in Philadelphia, will include timely updates on Ebola, including perspectives from physicians and scientists who have been involved with the response in West Africa and the US.In addition to providing these resources to our members, IDSA has also coordinated responses to several media inquiries about the outbreak. Thanks to the help of members of the Public Health Committee, we have been able to provide a science-based perspective to the general public’s understanding of the outbreak, the medical response, and the likelihood of the virus appearing in the US. In a recent story appearing in Salon, Jeff Duchin, MD, FIDSA, chair of IDSA’s Public Health Committee responded to a recent Harvard School of Public Health survey showing that over a quarter of Americans fear that they or someone in their family could become infected with the virus, explaining that the chances of a US outbreak are close to zero.
Additional Resources and Requests:
Oxford University Press, publisher of IDSA journals, has a collection of journal articles on Ebola, available free of charge at: www.oxfordjournals.org/en/our-journals/medicine-and-health/ebola.html
Centers for Disease Control and Prevention Advice for Humanitarian Aid Workers Traveling to Guinea, Liberia, Nigeria, or Sierra Leone during the Ebola OutbreakDoctors Without Borders/ Médecins Sans Frontières (MSF) is actively looking for medical personnel who can assist with the Ebola crisis in West Africa. They are looking for nurses and physicians with experience working in isolation wards and infection control. To learn more about the qualifications needed or to apply visit the Doctors Without Borders website.
Sign Up for AlertsMuch of the information provided above was shared with IDSA members through the two email services offered to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Other recent alerts have included:
Cubist Pharmaceuticals Issues Voluntary U.S. Recall Of Certain Lots Of CUBICIN
FDA approves Orbactiv to treat skin infections
IDSA members can log in to MyIDSA to sign up for these services online.
Is Your Facility Experiencing Antibiotic Shortages?IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at firstname.lastname@example.org.
< Previous Article | Next Article >